BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 26704150)

  • 1. Dopaminergic system and dream recall: An MRI study in Parkinson's disease patients.
    De Gennaro L; Lanteri O; Piras F; Scarpelli S; Assogna F; Ferrara M; Caltagirone C; Spalletta G
    Hum Brain Mapp; 2016 Mar; 37(3):1136-47. PubMed ID: 26704150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amygdala and hippocampus volumetry and diffusivity in relation to dreaming.
    De Gennaro L; Cipolli C; Cherubini A; Assogna F; Cacciari C; Marzano C; Curcio G; Ferrara M; Caltagirone C; Spalletta G
    Hum Brain Mapp; 2011 Sep; 32(9):1458-70. PubMed ID: 20740648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dreaming furiously? A sleep laboratory study on the dream content of people with Parkinson's disease and with or without rapid eye movement sleep behavior disorder.
    Valli K; Frauscher B; Peltomaa T; Gschliesser V; Revonsuo A; Högl B
    Sleep Med; 2015 Mar; 16(3):419-27. PubMed ID: 25683562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment with weak electromagnetic fields restores dream recall in a parkinsonian patient.
    Sandyk R
    Int J Neurosci; 1997 Jun; 90(1-2):75-86. PubMed ID: 9285289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resting brain activity varies with dream recall frequency between subjects.
    Eichenlaub JB; Nicolas A; Daltrozzo J; Redouté J; Costes N; Ruby P
    Neuropsychopharmacology; 2014 Jun; 39(7):1594-602. PubMed ID: 24549103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-sleep treatment with galantamine stimulates lucid dreaming: A double-blind, placebo-controlled, crossover study.
    LaBerge S; LaMarca K; Baird B
    PLoS One; 2018; 13(8):e0201246. PubMed ID: 30089135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dream structure in Parkinson's patients.
    Cipolli C; Bolzani R; Massetani R; Murri L; Muratorio A
    J Nerv Ment Dis; 1992 Aug; 180(8):516-23. PubMed ID: 1500934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of dopamine and cognitive impairment on neural reactivity to facial emotion in Parkinson's disease.
    Dan R; Růžička F; Bezdicek O; Roth J; Růžička E; Vymazal J; Goelman G; Jech R
    Eur Neuropsychopharmacol; 2019 Nov; 29(11):1258-1272. PubMed ID: 31607424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine-related dissociation of cortical and subcortical brain activations in cognitively unimpaired Parkinson's disease patients OFF and ON medications.
    Kim J; Zhang K; Cai W; YorkWilliams S; Ua Cruadhlaoich MAI; Llanes S; Menon V; Poston KL
    Neuropsychologia; 2018 Oct; 119():24-33. PubMed ID: 30040957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The neurocognition of dreaming: key questions and foci.
    Horton CL
    Emerg Top Life Sci; 2023 Dec; 7(5):477-486. PubMed ID: 38130166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of trimipramine on dream recall and dream emotions in depressive outpatients.
    Schredl M; Berger M; Riemann D
    Psychiatry Res; 2009 May; 167(3):279-86. PubMed ID: 19403177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ventral striatal network connectivity reflects reward learning and behavior in patients with Parkinson's disease.
    Petersen K; Van Wouwe N; Stark A; Lin YC; Kang H; Trujillo-Diaz P; Kessler R; Zald D; Donahue MJ; Claassen DO
    Hum Brain Mapp; 2018 Jan; 39(1):509-521. PubMed ID: 29086460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine modulates the response of the human amygdala: a study in Parkinson's disease.
    Tessitore A; Hariri AR; Fera F; Smith WG; Chase TN; Hyde TM; Weinberger DR; Mattay VS
    J Neurosci; 2002 Oct; 22(20):9099-103. PubMed ID: 12388617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopaminergic modulation of emotional memory in Parkinson's disease.
    Hälbig TD; Kopp UA; Wodarz F; Borod JC; Gracies JM; Ebersbach G; Kupsch A
    J Neural Transm (Vienna); 2008 Aug; 115(8):1159-63. PubMed ID: 18506391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence that non-dreamers do dream: a REM sleep behaviour disorder model.
    Herlin B; Leu-Semenescu S; Chaumereuil C; Arnulf I
    J Sleep Res; 2015 Dec; 24(6):602-9. PubMed ID: 26307463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EEG Frontal Alpha Asymmetry and Dream Affect: Alpha Oscillations over the Right Frontal Cortex during REM Sleep and Presleep Wakefulness Predict Anger in REM Sleep Dreams.
    Sikka P; Revonsuo A; Noreika V; Valli K
    J Neurosci; 2019 Jun; 39(24):4775-4784. PubMed ID: 30988168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can we still dream when the mind is blank? Sleep and dream mentations in auto-activation deficit.
    Leu-Semenescu S; Uguccioni G; Golmard JL; Czernecki V; Yelnik J; Dubois B; Forgeot d'Arc B; Grabli D; Levy R; Arnulf I
    Brain; 2013 Oct; 136(Pt 10):3076-84. PubMed ID: 24026624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SSRI treatment suppresses dream recall frequency but increases subjective dream intensity in normal subjects.
    Pace-Schott EF; Gersh T; Silvestri R; Stickgold R; Salzman C; Hobson JA
    J Sleep Res; 2001 Jun; 10(2):129-42. PubMed ID: 11422727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How we remember the stuff that dreams are made of: neurobiological approaches to the brain mechanisms of dream recall.
    De Gennaro L; Marzano C; Cipolli C; Ferrara M
    Behav Brain Res; 2012 Jan; 226(2):592-6. PubMed ID: 22024432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequent lucid dreaming associated with increased functional connectivity between frontopolar cortex and temporoparietal association areas.
    Baird B; Castelnovo A; Gosseries O; Tononi G
    Sci Rep; 2018 Dec; 8(1):17798. PubMed ID: 30542052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.